VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $264 | +10.9% | 9,801 | +19.5% | 0.06% | +19.2% |
Q2 2023 | $238 | -32.6% | 8,201 | -24.8% | 0.05% | -31.6% |
Q1 2023 | $353 | -100.0% | 10,911 | -73.1% | 0.08% | -72.4% |
Q4 2021 | $1,221,000 | -99.4% | 40,601 | +741.3% | 0.28% | +382.5% |
Q2 2020 | $205,628,000 | – | 4,826 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |